BRIEF—Sanofi appoints new global R&D boss after retirement

Following the retirement of global R&D head Elias Zerhouni, Sanofi announced John Reed will take up the position from the start of July.

Dr Reed, who will report directly to the chief executive and will become a member of the executive committee, joins the company from Swiss giant Roche, where he served in a similar role.

At Roche, Dr Reed was responsible for directing research and early development activities through Phase IIb across all therapeutic areas, including oncology, immunology, rare diseases, neuroscience, ophthalmology and infectious diseases.